GO
Loading...

Squawk Box

More

  • Sir Richard's fight for Love     Tuesday, 6 May 2014 | 8:32 AM ET

    Sir Richard Branson, Virgin Group founder, talks about Virgin America's struggle for two gates at Love Field in Dallas. When you have no competition as in Love Field, fares go up, says Branson.

  • March trade deficit $40.38 billion     Tuesday, 6 May 2014 | 8:30 AM ET

    CNBC's Rick Santelli breaks down the data on international trade. And CNBC's Steve Liesman provides insight on the import/export numbers.

  • Richard Branson's vision for NY to Tokyo in 1 hour Tuesday, 6 May 2014 | 11:26 AM ET
    Sir Richard Branson, Virgin Group founder and chairman

    Virgin Group founder Richard Branson also tells CNBC that it's a great time to invest in the airline industry, but for the travelers "the jury is still out" on whether that's good news.

  • Tenet CEO: ER visits are still on the rise Tuesday, 6 May 2014 | 10:54 AM ET
    Tenet Healthcare's medical center in Atlanta

    Emergency rooms are no less crowded since Obamacare started, Trevor Fetter, CEO of hospital operator Tenet Healthcare, tells CNBC.

  • Trevor Fetter, president & CEO of Tenet Healthcare, discusses how the Affordable Care Act has impacted the health care industry and the problem of the uninsured.

  • Fixated on fixed income     Tuesday, 6 May 2014 | 8:07 AM ET

    People have rediscovered the value of traditional bonds in their portfolios, says Jeff Rosenberg, BlackRock chief investment strategist for fixed income, sharing his outlook on bonds and how to play the fixed income space.

  • Where the rich invest     Tuesday, 6 May 2014 | 7:51 AM ET

    CNBC's Robert Frank reveals the results of CNBC's Millionaire Survey, which shows how the wealthy feel about the markets and where they are putting their money to work.

  • Ronald DeFeo, chairman & CEO of Terex Corporation, weighs in on corporate tax reform and his plan to remain globally competitive.

  • Recovery trends: Rod & reel vs. line & bait     Tuesday, 6 May 2014 | 7:32 AM ET

    Martin Franklin, Jarden executive chairman, explains why consumers appear to be less stressed this year.

  • CNBC's Kate Kelly shares highlights from the Sohn Conference on what major hedge fund managers are thinking about the markets and U.S. economy.

  • Robert Kahn, Council on Foreign Relations, explains why financial sanctions will have a powerful impact on Russia.

  • 'Big uglies' profit in a mixed market     Tuesday, 6 May 2014 | 7:05 AM ET

    Gary Kaminsky, Morgan Stanley, and Phil Orlando, Federated chief equity strategist, weigh in on what investors should make of the market's lack of direction, and why it pays for investors to have fixed income in their portfolios.

  • Aspirin and suntan lotion? Bayer, Merck do deal Tuesday, 6 May 2014 | 7:13 AM ET
    Merck employees walk past a Merck sign in front of the company's building in Summit, New Jersey.

    Bayer will acquire the consumer care business of U.S.-based Merck & Co for $14.2 billion in cash, the company said in a statement Tuesday.

  • Bayer buys Merck's over-the-counter unit     Tuesday, 6 May 2014 | 8:04 AM ET

    CNBC's Meg Tirrell reports the latest details on Bayer's deal to buy Merck's U.S. consumer care business for $14.2 billion. The brands include Claritin, Coppertone, Afrin and more.

  • CNBC's Robert Frank rolls out the results from the first CNBC Millionaire Survey, where respondents sound off on achieving the American dream.

  • What the yield curve shows     Tuesday, 6 May 2014 | 6:37 AM ET

    Jim O'Sullivan, High Frequency Economics chief economist, shares his outlook on GDP for 2014. And Greg McGreevey, Invesco head of fixed income, explains what's keeping Treasury rates down.

  • Global markets: European stocks mixed     Tuesday, 6 May 2014 | 6:15 AM ET

    CNBC's Ross Westgate reports on all the market moving events from Europe, as investors focus on violence in Ukraine and mixed earnings results.

  • I am not a big fan of sanctions: Bayer CEO     Tuesday, 6 May 2014 | 6:10 AM ET

    Marijn Dekkers, Bayer CEO, shares his thoughts on imposing additional sanctions on Russia. I think it's important to sit around the table and come up with diplomatic solutions, says Dekkers.

  • Bayer CEO: Growth huge part of Merck deal     Tuesday, 6 May 2014 | 6:05 AM ET

    Marijn Dekkers, Bayer CEO, discusses the details of his company's acquisition of Merck's consumer unit. Bayer can take these products and position them stronger outside the United States, says Dekkers.

  • Ukraine vs economy: What matters to market? Monday, 5 May 2014 | 4:30 PM ET
    Traders work on the floor of the New York Stock Exchange on Monday.

    Two pros agree that the crisis in Ukraine shouldn't have a long-term effect on the market.

About Squawk Box

  • "Squawk Box" is the ultimate "pre-market" morning news and talk program, where the biggest names in business and politics tell their most important stories. Anchored by Joe Kernen, Becky Quick and Andrew Ross Sorkin, the show brings Wall Street to Main Street. It's a "must see" for everyone from the professional trader to the casual investor.

Contact Squawk Box

  • Showtimes

    U.S.
    Weekdays 6a ET
    EMEA
    Weekdays 13:00 CET
    Asia
    Weekdays 18:00 SIN/HK
    Australia
    Weekdays 20:00 SYD
    New Zealand
    Weekdays 22:00 NZ

 

  • Joe Kernen is co-anchor of "Squawk Box," CNBC's signature morning program.

  • "Squawk Box" Co-Anchor

  • Andrew Ross Sorkin is a co-anchor of "Squawk Box," a financial columnist for "The New York Times" and the editor-at-large of NYT's DealBook.